Lifevantage ROE 2010-2024 | LFVN

Current and historical return on equity (ROE) values for Lifevantage (LFVN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Lifevantage ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-03-31 $0.00B $0.03B 13.56%
2023-12-31 $0.00B $0.03B 9.68%
2023-09-30 $0.00B $0.03B 9.30%
2023-06-30 $0.00B $0.04B 9.09%
2023-03-31 $0.00B $0.03B 0.00%
2022-12-31 $0.00B $0.03B 0.00%
2022-09-30 $0.00B $0.03B 3.01%
2022-06-30 $0.00B $0.03B 8.70%
2022-03-31 $0.01B $0.03B 25.17%
2021-12-31 $0.01B $0.04B 27.59%
2021-09-30 $0.01B $0.04B 38.36%
2021-06-30 $0.01B $0.04B 36.36%
2021-03-31 $0.01B $0.04B 34.53%
2020-12-31 $0.01B $0.04B 36.36%
2020-09-30 $0.01B $0.03B 38.40%
2020-06-30 $0.01B $0.03B 39.67%
2020-03-31 $0.01B $0.03B 41.74%
2019-12-31 $0.01B $0.03B 43.24%
2019-09-30 $0.01B $0.03B 34.95%
2019-06-30 $0.01B $0.03B 32.99%
2019-03-31 $0.01B $0.03B 30.43%
2018-12-31 $0.01B $0.02B 32.56%
2018-09-30 $0.01B $0.02B 29.27%
2018-06-30 $0.01B $0.02B 32.43%
2018-03-31 $0.00B $0.02B 17.91%
2017-12-31 $0.00B $0.02B 6.45%
2017-09-30 $0.00B $0.02B 6.67%
2017-06-30 $0.00B $0.02B 6.90%
2017-03-31 $0.00B $0.01B 22.22%
2016-12-31 $0.00B $0.02B 32.65%
2016-09-30 $0.01B $0.01B 58.54%
2016-06-30 $0.01B $0.01B 75.00%
2016-03-31 $0.00B $0.01B 66.67%
2015-12-31 $0.00B $0.01B 88.89%
2015-09-30 $0.00B $0.01B 75.00%
2015-06-30 $0.01B $0.00B 155.56%
2015-03-31 $0.01B $0.00B 189.47%
2014-12-31 $0.01B $0.01B 210.53%
2014-09-30 $0.01B $0.01B 369.23%
2014-06-30 $0.01B $0.00B 97.56%
2014-03-31 $0.01B $0.00B 45.07%
2013-12-31 $0.01B $-0.00B 34.95%
2013-09-30 $0.01B $0.04B 17.27%
2013-06-30 $0.01B $0.03B 20.29%
2013-03-31 $0.01B $0.04B 36.36%
2012-12-31 $0.00B $0.04B 13.33%
2012-09-30 $0.01B $0.03B 55.32%
2012-06-30 $0.01B $0.03B 118.18%
2012-03-31 $-0.04B $0.02B 3120.00%
2011-12-31 $-0.04B $0.01B 429.27%
2011-09-30 $-0.05B $-0.02B 349.09%
2011-06-30 $-0.05B $-0.02B 408.00%
2011-03-31 $-0.01B $-0.01B 80.00%
2010-12-31 $-0.01B $-0.01B 62.22%
2010-09-30 $-0.01B $-0.01B 115.56%
2010-06-30 $-0.01B $-0.02B 133.33%
2010-03-31 $-0.01B $-0.01B 173.33%
2009-12-31 $-0.01B $-0.01B 152.38%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.091B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.803B 20.15
Becton Dickinson (BDX) United States $67.876B 19.20
West Pharmaceutical Services (WST) United States $24.549B 44.00
Cardinal Health (CAH) United States $23.385B 13.37
Align Technology (ALGN) United States $19.876B 38.38
Cooper (COO) United States $19.232B 29.10
Labcorp (LH) United States $17.310B 14.90
Henry Schein (HSIC) United States $9.380B 16.69
DENTSPLY SIRONA (XRAY) United States $5.855B 15.16
Merit Medical Systems (MMSI) United States $4.783B 26.21
CONMED (CNMD) United States $2.306B 20.91
Patterson (PDCO) United States $2.223B 10.65
STAAR Surgical (STAA) United States $2.089B 80.21
Atrion (ATRI) United States $0.794B 42.41
Pro-Dex (PDEX) United States $0.065B 33.02
Biolase (BIOL) United States $0.005B 0.00